Saudi Arabia Pemetrexed Market Size & Outlook, 2025-2033


Saudi Arabia Pemetrexed Market Insights

  • Reed Intelligence analysis indicates that the Saudi Arabia Pemetrexed Market size, valued at USD 60.64 Million in 2024, is expected to expand to USD 70.64 Million by 2033.
  • The Saudi Arabia market is forecasted to expand at a CAGR of 1.73% spanning 2026–2033.
  • Malignant Pleural Mesothelioma held the leading position among By Application segments in 2024, based on market size.
  • Non-Squamous NSCLC is projected to post the fastest growth rate, sustaining its position as the most attractive By Application segment during the forecast horizon.

Other Key Findings


  • Saudi Arabia accounted for 2.59% of the global Pemetrexed Market size in 2024.
  • By 2033, United States is expected to remain the top global market in terms of size.
  • Within Middle East and Africa, United Arab Emirates is forecasted to dominate the regional Pemetrexed Market size by 2033.
  • Nigeria will be the fastest-growing market in Middle East and Africa, projected to achieve USD 13.89 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 60.64 Million
Market Size In 2033 USD 70.64 Million
Largest segment Malignant Pleural Mesothelioma
Units Revenue in USD Million
CAGR 1.73% (2025-2033)
Segmnetation Covered
By Application
  1. Malignant Pleural Mesothelioma
  2. Non-Squamous NSCLC
By End-User
  1. Hospitals
  2. Oncology Centers
  3. Online Pharmacies
  4. Offline Pharmacies
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends